Brainsway Ltd Sponsored ADR Stock News
$10.22
0.20%
yesterday
Nasdaq,
Jun 02, 10:00 pm CET
Brainsway Ltd Sponsored ADR Stock News
Neutral
Seeking Alpha
●
21 days ago
BrainsWay Ltd. (NASDAQ:BWAY ) Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ET Company Participants Brian Ritchie – LifeSci Advisors LLC Hadar Levy – Chief Executive Officer Ido Marom – Chief Financial Officer Conference Call Participants Steve Lichtman – Oppenheimer & Company Operator Good day, and welcome to the BrainsWay First Quarter 2025 Earnings Conference Call.
Neutral
GlobeNewsWire
●
21 days ago
Achieved r ecord quarterly s ales of $11. 5 million in Q 1 202 5 , an increase of 27% compared to Q 1 202 4
Neutral
Seeking Alpha
●
3 months ago
BrainsWay Ltd. (NASDAQ:BWAY ) Q4 2024 Earnings Conference Call March 11, 2025 8:30 AM ET Company Participants Brian Ritchie - Investor Relations, LifeSci Advisors Hadar Levy - Chief Executive Officer Ido Marom - Chief Financial Officer Conference Call Participants Steven Lichtman - Oppenheimer Jeffrey S.
Neutral
GlobeNewsWire
●
3 months ago
Achieved r ecord quarterly s ales of $11.4 million in Q4 2024 , an increase of 27% compared with Q4 2023
Neutral
GlobeNewsWire
●
6 months ago
BURLINGTON, Mass. and JERUSALEM, Dec. 12, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced non-invasive treatment of brain disorders, today announced recent positive pilot data from an independent, third-party study conducted at Stanford University evaluating an accelerated protocol using the Company's Deep Transcrania...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
